Page last updated: 2024-11-06

phenylglycine nitrile

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phenylglycine nitrile: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID76372
CHEMBL ID1229843
SCHEMBL ID197012
MeSH IDM0444749

Synonyms (45)

Synonym
einecs 221-129-0
n-phenylglycinenitrile
ai3-02755
acetonitrile, phenylamino-
brn 2206191
nsc 7611
CHEMBL1229843
xbn69be6x2 ,
unii-xbn69be6x2
ec 221-129-0
3009-97-0
acetonitrile, anilino-
1-anilinoacetonitrile
nsc7611
wln: nc1mr
glycinonitrile, n-phenyl-
acetonitrile, (phenylamino)-
phenylglycine nitrile
anilinoacetonitrile
(phenylamino)acetonitrile
nsc-7611
n-(cyanomethyl)aniline
2-anilinoacetonitrile
AKOS000253573
HMS1719B17
A820195
2-(phenylamino)acetonitrile
n-phenylglycinonitrile
FT-0634598
SCHEMBL197012
n-cyanomethylaniline
KAXCEFLQAYFJKV-UHFFFAOYSA-N
mfcd00044430
W-106957
n-phenylglycinonitrile, aldrichcpr
acetonitrile, anilino- (8ci)
DTXSID80184175
Z56347332
phenylaminoacetonitril
EN300-16652
STR05177
H12014
Q27452740
acetonitrile, 2-(phenylamino)-
CS-W021451
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1640019Luciferase/luciferin-expressing antifolate-resistant parasites were used to infect a culture of HepG2 cells that were pre-incubated with compounds. Infected hepatocytes emit light due to the luciferase reaction. Assay results are presented as the percent 2018Science (New York, N.Y.), 12-07, Volume: 362, Issue:6419
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
AID1640018Luciferase/luciferin-expressing antifolate-resistant parasites were used to infect a culture of HepG2 cells that were pre-incubated with compounds. Infected hepatocytes emit light due to the luciferase reaction. Assay results are presented as the percent 2018Science (New York, N.Y.), 12-07, Volume: 362, Issue:6419
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.79 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]